High Mark Wealth Management LLC Centessa Pharmaceuticals PLC Transaction History
High Mark Wealth Management LLC
- $217 Million
- Q3 2025
A detailed history of High Mark Wealth Management LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, High Mark Wealth Management LLC holds 237,285 shares of CNTA stock, worth $6.55 Million. This represents 2.66% of its overall portfolio holdings.
Number of Shares
237,285
Previous 237,285
-0.0%
Holding current value
$6.55 Million
Previous $3.12 Million
84.6%
% of portfolio
2.66%
Previous 1.57%
Shares
5 transactions
Others Institutions Holding CNTA
# of Institutions
139Shares Held
125MCall Options Held
1.49MPut Options Held
787K-
Medicxi Ventures Management (Jersey) LTD20MShares$551 Million73.31% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.8MShares$298 Million3.58% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10MShares$277 Million0.41% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$275 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$267 Million8.3% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.6B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...